Reneuron Group News Today

/PRNewswire/ -- The global stem cell therapy market size is estimated to grow by USD 11.65 billion from 2023-2027, according to Technavio. The market is...

The industry is predicted to experience a notable expansion with a predicted global diagnostic exosome biomarkers market demand of US$ 196.8 million by 2023. The diagnostic exosome biomarkers sales are anticipated to thrive at a healthy CAGR of 16.3% between 2023 and 2033. A valuation of US$ 888.5 million is predict...

ReNeuron Group plc (LON:RENE – Get Free Report) shares were up 11.4% on Thursday . The stock traded as high as GBX 4.15 ($0.05) and last traded at GBX 3.90 ($0.05). Approximately 2,480,290 shares were traded during trading, an increase of 130% from the average daily volume of 1,076,155 shares. The stock had previously closed […]

ReNeuron Group plc (LON:RENE – Get Free Report)’s share price hit a new 52-week low during mid-day trading on Wednesday . The stock traded as low as GBX 4.25 ($0.05) and last traded at GBX 4 ($0.05), with a volume of 101044 shares trading hands. The stock had previously closed at GBX 4.75 ($0.06). ReNeuron […]

ReNeuron Group plc (LON:RENE – Get Free Report)’s stock price hit a new 52-week low during trading on Wednesday . The stock traded as low as GBX 4.25 ($0.05) and last traded at GBX 4 ($0.05), with a volume of 101044 shares changing hands. The stock had previously closed at GBX 4.75 ($0.06). ReNeuron Group […]

ReNeuron Group PLC on Wednesday reported a slight narrowing in interim loss as costs decreased, as it highlighted its focus on its exosome delivery platform. The Brigdend, Wales-based stem cell and...

ReNeuron Group PLC (AIM:RENE, OTC:RNUGF) is to present in vivo data exemplifying the cellular and tissue targeting capabilities and highlighting the...

The Stem Cell Therapies Market is anticipated to increase from US$ 187 million in 2021 to US$ 401 million by 2026, at a CAGR of 16.7%, by 2032.The COVID-19 pandemic has caused severe impacts on the global economy at various levels and which can be seen on the Healthcare industry as well. The thriving market of healt...

We feel now is a pretty good time to analyse ReNeuron Group plc's ( LON:RENE ) business as it appears the company may...

EQS-News: / Key word(s): Research Update/Research Update ReNeuron Group (RENE): A step forward on the Exosome delivery platform 18.09.2023 / 08:15 CET/CEST The issuer is solely responsible for the content of this announcement.   London, UK, 18 September 2023   ReNeuron Group (RENE): A step forwa...